NBE-Therapeutics
Research in cancer treatment
Total raised
€62M
€62,429,225
Funding rounds
4
Investors
3
distinct backers
Active since
2015-02
latest 2020-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood20
base rate 51% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 4 rounds raised
- ▲ €30M+ raised
- ▲ 14y since founding
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-10-01 | Series C | €20M | Boehringer Ingelheim,PPF Group | View deal → |
| 2020-09-10 | Other | €21M | — | View deal → |
| 2016-11-01 | Series B | €19M | Boehringer Ingelheim Venture Fund,PPF Group | View deal → |
| 2015-03-01 | Series A | €2.8M | Boehringer Ingelheim Venture Fund | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy